Immunovia Publ (Sweden) Price on April 18, 2024
| IMMNOV Stock | SEK 0.72 0.04 5.26% |
If you're considering investing in Immunovia Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immunovia Publ stands at 0.72, as last reported on the 11th of December 2024, with the highest price reaching 0.84 and the lowest price hitting 0.72 during the day. Immunovia Publ appears to be out of control, given 3 months investment horizon. Immunovia publ AB holds Efficiency (Sharpe) Ratio of 0.0403, which attests that the entity had a 0.0403% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Immunovia publ AB, which you can use to evaluate the volatility of the firm. Please utilize Immunovia Publ's Downside Deviation of 8.33, risk adjusted performance of 0.0384, and Market Risk Adjusted Performance of (0.78) to validate if our risk estimates are consistent with your expectations.
Immunovia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immunovia |
Sharpe Ratio = 0.0403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IMMNOV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.31 actual daily | 91 91% of assets are less volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Immunovia Publ is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunovia Publ by adding it to a well-diversified portfolio.
Immunovia Publ Valuation on April 18, 2024
It is possible to determine the worth of Immunovia Publ on a given historical date. On April 18, 2024 Immunovia was worth 1.76 at the beginning of the trading date compared to the closed value of 1.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunovia Publ stock. Still, in general, we apply an absolute valuation method to find Immunovia Publ's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunovia Publ where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunovia Publ's related companies.
| Open | High | Low | Close | Volume | |
| 1.87 | 1.95 | 1.72 | 1.75 | 158,116 | |
04/18/2024 | 1.76 | 1.89 | 1.75 | 1.79 | 109,354 |
| 1.82 | 1.83 | 1.70 | 1.75 | 233,227 |
| Backtest Immunovia Publ | | | Immunovia Publ History | | | Immunovia Publ Valuation | Previous | Next |
Immunovia Publ Trading Date Momentum on April 18, 2024
| On April 19 2024 Immunovia publ AB was traded for 1.75 at the closing time. The highest price during the trading period was 1.83 and the lowest recorded bid was listed for 1.70 . The volume for the day was 233.2 K. This history from April 19, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 2.23% . The trading delta at closing time to the current price is 18.44% . |
Immunovia publ AB Fundamentals Correlations and Trends
By evaluating Immunovia Publ's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunovia Publ's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunovia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunovia Publ Stock history
Immunovia Publ investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunovia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunovia publ AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunovia Publ stock prices may prove useful in developing a viable investing in Immunovia Publ
Immunovia AB , a molecular diagnostics company, develops and commercializes diagnostic tools for cancer and autoimmune diseases in Sweden and internationally. Immunovia AB was founded in 2007 and is headquartered in Lund, Sweden. Immunovia operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 46 people.
Immunovia Publ Stock Technical Analysis
Immunovia Publ technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunovia Publ Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Immunovia publ AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immunovia Publ December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunovia Publ stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunovia Publ shares will generate the highest return on investment. By undertsting and applying Immunovia Publ stock market strength indicators, traders can identify Immunovia publ AB entry and exit signals to maximize returns
Immunovia Publ Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunovia Publ's price direction in advance. Along with the technical and fundamental analysis of Immunovia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunovia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0384 | |||
| Jensen Alpha | 0.464 | |||
| Total Risk Alpha | (1.23) | |||
| Sortino Ratio | 0.0349 | |||
| Treynor Ratio | (0.79) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Immunovia Stock analysis
When running Immunovia Publ's price analysis, check to measure Immunovia Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovia Publ is operating at the current time. Most of Immunovia Publ's value examination focuses on studying past and present price action to predict the probability of Immunovia Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovia Publ's price. Additionally, you may evaluate how the addition of Immunovia Publ to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |